These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


752 related items for PubMed ID: 11850896

  • 1. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
    Dima VF, Ionescu MD, Palade R, Balotescu C, Becheanu G, Dima SV.
    Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
    [Abstract] [Full Text] [Related]

  • 2. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
    Tobias J, Lebens M, Bölin I, Wiklund G, Svennerholm AM.
    Vaccine; 2008 Feb 06; 26(6):743-52. PubMed ID: 18191006
    [Abstract] [Full Text] [Related]

  • 3. Immune response to Escherichia coli antigens entrapped in liposomes. I. Immunopathological studies.
    Dima VF, Popescu C, Postoarcă A, Ionescu MD, Oproiu G, Lacky D, Balotescu C, Dima SV.
    Roum Arch Microbiol Immunol; 1999 Feb 06; 58(3-4):223-39. PubMed ID: 11845460
    [Abstract] [Full Text] [Related]

  • 4. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO, Luiz WB, Sbrogio-Almeida ME, Ferreira LC.
    Vaccine; 2005 Mar 31; 23(19):2430-8. PubMed ID: 15752829
    [Abstract] [Full Text] [Related]

  • 5. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
    Turner AK, Beavis JC, Stephens JC, Greenwood J, Gewert C, Thomas N, Deary A, Casula G, Daley A, Kelly P, Randall R, Darsley MJ.
    Infect Immun; 2006 Feb 31; 74(2):1062-71. PubMed ID: 16428753
    [Abstract] [Full Text] [Related]

  • 6. Characterization of colonization factor antigen CFA/I from an enterotoxigenic Escherichia coli strain (0128:H12).
    Dima VF, Petrovici A, Dima SV.
    Arch Roum Pathol Exp Microbiol; 1990 Feb 31; 49(4):297-313. PubMed ID: 1983732
    [Abstract] [Full Text] [Related]

  • 7. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO, Luiz WB, Sbrogio-Almeida ME, Nishimura LS, Guth BE, Ferreira LC.
    Infect Immun; 2004 Nov 31; 72(11):6480-91. PubMed ID: 15501779
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.
    Remer KA, Bartrow M, Roeger B, Moll H, Sonnenborn U, Oelschlaeger TA.
    Int J Med Microbiol; 2009 Nov 31; 299(7):467-78. PubMed ID: 19467927
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria.
    Tobias J, Holmgren J, Hellman M, Nygren E, Lebens M, Svennerholm AM.
    Vaccine; 2010 Oct 08; 28(43):6977-84. PubMed ID: 20728524
    [Abstract] [Full Text] [Related]

  • 14. Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.
    Tobias J, Svennerholm AM.
    Appl Microbiol Biotechnol; 2012 Mar 08; 93(6):2291-300. PubMed ID: 22350259
    [Abstract] [Full Text] [Related]

  • 15. Studies on formulation of a combination heat killed immunogen from diarrheagenic Escherichia coli and Vibrio cholerae in RITARD model.
    Mukherjee P, Mondal V, Bhaumik U, Sinha R, Sarkar S, Mitra S, Howlader DR, Maiti S, Mukhopadhyay AK, Dutta S, Koley H.
    Microbes Infect; 2019 Mar 08; 21(8-9):368-376. PubMed ID: 30853357
    [Abstract] [Full Text] [Related]

  • 16. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
    Holmgren J, Bourgeois L, Carlin N, Clements J, Gustafsson B, Lundgren A, Nygren E, Tobias J, Walker R, Svennerholm AM.
    Vaccine; 2013 May 07; 31(20):2457-64. PubMed ID: 23541621
    [Abstract] [Full Text] [Related]

  • 17. The polymeric stability of the Escherichia coli F4 (K88) fimbriae enhances its mucosal immunogenicity following oral immunization.
    Verdonck F, Joensuu JJ, Stuyven E, De Meyer J, Muilu M, Pirhonen M, Goddeeris BM, Mast J, Niklander-Teeri V, Cox E.
    Vaccine; 2008 Oct 23; 26(45):5728-35. PubMed ID: 18762221
    [Abstract] [Full Text] [Related]

  • 18. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A, Giraldo A, Castañeda E, Martínez M, de la Hoz F, Rivas F, Depetris A, Svennerholm AM, Sack DA.
    Bull Pan Am Health Organ; 1995 Dec 23; 29(4):312-21. PubMed ID: 8605522
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S, Ahmed T, Mannoor K, Begum YA, Bardhan PK, Sack RB, Sack DA, Svennerholm AM, Holmgren J, Qadri F.
    Vaccine; 2009 Feb 25; 27(9):1386-92. PubMed ID: 19146897
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 38.